For help on how to get the results you want, see our search tips.
531 results
Medicine type
Orphan medicine Remove Orphan medicine filter
-
List item
Human medicine European public assessment report (EPAR): Verkazia (updated)
ciclosporin, Conjunctivitis, Keratitis
Date of authorisation: 06/07/2018,
, Revision: 2, Authorised, Last updated: 11/07/2019
-
List item
Human medicine European public assessment report (EPAR): Ocaliva (updated)
Obeticholic acid, Liver Cirrhosis, Biliary
Date of authorisation: 12/12/2016,
, , 
, Revision: 5, Authorised, Last updated: 10/07/2019
-
List item
Human medicine European public assessment report (EPAR): Qarziba (previously Dinutuximab beta EUSA and Dinutuximab beta Apeiron) (updated)
dinutuximab beta, Neuroblastoma
Date of authorisation: 08/05/2017,, , 
, Revision: 6, Authorised, Last updated: 10/07/2019
-
List item
Human medicine European public assessment report (EPAR): Raxone (updated)
idebenone, Optic Atrophy, Hereditary, Leber
Date of authorisation: 08/09/2015,, , , Revision: 3, Authorised, Last updated: 10/07/2019
-
List item
Human medicine European public assessment report (EPAR): Firdapse (previously Zenas) (updated)
amifampridine, Lambert-Eaton Myasthenic Syndrome
Date of authorisation: 23/12/2009,, , , Revision: 16, Authorised, Last updated: 05/07/2019
-
List item
Human medicine European public assessment report (EPAR): Revatio (updated)
sildenafil, Hypertension, Pulmonary
Date of authorisation: 28/10/2005,, Revision: 37, Authorised, Last updated: 01/07/2019
-
List item
Human medicine European public assessment report (EPAR): Zejula (updated)
niraparib tosylate monohydrate, Fallopian Tube Neoplasms, Peritoneal Neoplasms, Ovarian Neoplasms
Date of authorisation: 16/11/2017,, , Revision: 5, Authorised, Last updated: 26/06/2019
-
List item
Human medicine European public assessment report (EPAR): Spinraza (updated)
nusinersen sodium, Muscular Atrophy, Spinal
Date of authorisation: 30/05/2017,, , Revision: 7, Authorised, Last updated: 25/06/2019
-
List item
Human medicine European public assessment report (EPAR): Bavencio (updated)
avelumab, Neuroendocrine Tumors
Date of authorisation: 18/09/2017,, , , Revision: 4, Authorised, Last updated: 25/06/2019
-
List item
Human medicine European public assessment report (EPAR): Defitelio (updated)
defibrotide, Hepatic Veno-Occlusive Disease
Date of authorisation: 18/10/2013,, , , Revision: 8, Authorised, Last updated: 25/06/2019
-
List item
Human medicine European public assessment report (EPAR): Pedea (updated)
Ibuprofen, Ductus Arteriosus, Patent
Date of authorisation: 28/07/2004,, Revision: 14, Authorised, Last updated: 18/06/2019
-
List item
Human medicine European public assessment report (EPAR): Onpattro (updated)
patisiran sodium, Amyloidosis, Familial
Date of authorisation: 27/08/2018,, , Revision: 2, Authorised, Last updated: 18/06/2019
-
List item
Human medicine European public assessment report (EPAR): Imnovid (previously Pomalidomide Celgene) (updated)
Pomalidomide, Multiple Myeloma
Date of authorisation: 05/08/2013,, , Revision: 15, Authorised, Last updated: 18/06/2019
-
List item
Human medicine European public assessment report (EPAR): Wilzin
zinc, Hepatolenticular Degeneration
Date of authorisation: 12/10/2004,, Revision: 11, Authorised, Last updated: 14/06/2019
-
List item
Human medicine European public assessment report (EPAR): Cystadrops
mercaptamine hydrochloride, Cystinosis
Date of authorisation: 18/01/2017,, Revision: 5, Authorised, Last updated: 14/06/2019
-
List item
Human medicine European public assessment report (EPAR): Onivyde
irinotecan hydrochloride trihydrate, Pancreatic Neoplasms
Date of authorisation: 14/10/2016,, Revision: 3, Authorised, Last updated: 13/06/2019
-
List item
Human medicine European public assessment report (EPAR): Translarna
Ataluren, Muscular Dystrophy, Duchenne
Date of authorisation: 31/07/2014,, , , Revision: 11, Authorised, Last updated: 13/06/2019
-
List item
Human medicine European public assessment report (EPAR): Revlimid
lenalidomide, Multiple Myeloma, Lymphoma, Mantle-Cell, Myelodysplastic Syndromes
Date of authorisation: 14/06/2007,, , Revision: 38, Authorised, Last updated: 11/06/2019
-
List item
Human medicine European public assessment report (EPAR): Xermelo
telotristat etiprate, Carcinoid Tumor, Neuroendocrine Tumors
Date of authorisation: 17/09/2017,, , Revision: 5, Authorised, Last updated: 05/06/2019
-
List item
Human medicine European public assessment report (EPAR): Farydak
panobinostat lactate anhydrous, Multiple Myeloma
Date of authorisation: 28/08/2015,, , Revision: 6, Authorised, Last updated: 05/06/2019
-
List item
Human medicine European public assessment report (EPAR): Kyprolis
carfilzomib, Multiple Myeloma
Date of authorisation: 19/11/2015,, , Revision: 14, Authorised, Last updated: 05/06/2019
-
List item
Human medicine European public assessment report (EPAR): Cayston
aztreonam lysine, Cystic Fibrosis, Respiratory Tract Infections
Date of authorisation: 21/09/2009,, Revision: 17, Authorised, Last updated: 04/06/2019
-
List item
Human medicine European public assessment report (EPAR): Prevymis
Letermovir, Cytomegalovirus Infections
Date of authorisation: 08/01/2018,, , Revision: 3, Authorised, Last updated: 04/06/2019
-
List item
Human medicine European public assessment report (EPAR): Trisenox
Arsenic trioxide, Leukemia, Promyelocytic, Acute
Date of authorisation: 05/03/2002,, Revision: 26, Authorised, Last updated: 03/06/2019
-
List item
Human medicine European public assessment report (EPAR): Palynziq
Pegvaliase, Phenylketonurias
Date of authorisation: 03/05/2019,, , Authorised, Last updated: 29/05/2019